The independently-produced feature film 'Blame' took home the best actress prize at the 2017 Tribeca Film Festival. But the story of how the movie actually got to the festival in the first place is just as interesting as its subject matter. We're joined now by actress Nadia Alexander, and Quinn Shephard, who wrote, directed, produced, and acted in the film. Shephard has been working on "Blame," a modern retelling of "The Crucible," since she was 15. She began to make the film at age 20, only to have her main investor pulled out at the last minute. Shephard liquidated her college fund to pay for the production. When she was left without any money for post-production, she called in favors, worked out deals, and lived in basements while editing it herself. Actress Nadia Alexander won the Best Actress Award at Tribeca. Both women agree that the #MeToo era has opened more doors for women in the industry.

Share:
More In Culture
Need2Know: Ukraine Aid Package, GDP Shrinks & Beijing Lockdown
Catching you up on what you need to know on April 29, 2022, with President Biden asking Congress for a $33 billion aid package for Ukraine, a shrinking GDP potentially leading to a recession, Beijing banning weddings and funerals while closings schools amid COVID, and more.
First-Time Homebuyers Face Rising Mortgage Rates
Buying a new home is tough right now; but for first-time buyers, it's an especially challenging time, with obstacles like rising mortgage rates and record-breaking home prices. The housing market is not expected to get much friendlier, as mortgage rates are expected to continue to climb as the Federal Reserve proceeds with its plans for rate hikes in an effort to stifle inflation. Jonathan Miller, President and CEO of real estate appraiser Miller Samuel, joins Cheddar News' Closing Bell to discuss.
CVS Health Backs Virtual Care and Digital Medicine Provider Biofourmis in $300 Million Funding Round
Virtual care and digital medicine provider Biofourmis recently raised $300 million in a Series D round led by General Atlantic and with participation from CVS Health. Biofourmis offers at-home care and digital therapies backed by artificial intelligence, which can remotely monitor patients while they are at home. The company says it hopes its technology can improve patient outcomes while reducing the cost and burden of care. Kuldeep Signh Rajput, Founder and CEO of Biofourmis, joins Cheddar News' Closing Bell to discuss.
Load More